针对细胞癌的免疫治疗的现状和未来前景
Leandro Blas1, Keisuke Monji2, Jun Mutaguchi1
1Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
International journal of clinical oncology
|December 18, 2023
概括
免疫检查点抑制剂 (ICI) 已经改变了晚期细胞癌 (RCC) 治疗,在各种环境中成为标准. 研究继续探索新的组合和辅助疗法,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞癌研究 细胞癌研究
背景情况:
- 晚期细胞癌 (RCC) 治疗在过去十年里有了显著的进化.
- 免疫检查点抑制剂 (ICI) 的出现是这种进化的主要驱动力.
- 现在ICI单疗法和组合疗法是第一线和后续线治疗的标准.
研究的目的:
- 审查目前关于RCC患者免疫治疗的证据.
- 总结随机对照试验和正在进行的研究的发现.
- 讨论RCC免疫疗法的未来前景.
主要方法:
- 对RCC免疫疗法的当前证据的文献综述.
- 随机对照试验 (RCT) 和正在进行的临床研究的分析.
- 综合最近的发现和未来的研究方向.
主要成果:
- 免疫检查点抑制剂 (ICI) 已被确立为高级RCC的标准治疗方法.
- 基于ICI的组合与向治疗 (TKI,mTOR,VEGF) 在各种治疗线路中是有效的.
- 辅助免疫疗法和强化组合治疗是正在积极研究的领域.
结论:
- 免疫疗法,特别是ICI,已经彻底改变了先进的RCC管理.
- 目前正在进行的研究重点是优化组合策略和辅助免疫治疗.
- 未来的方向包括探索新的生物标志物和更密集的治疗方案.
更多相关视频
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
33.6K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
792
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376
Cytotoxic T Cells-mediated Immune Response
923
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923
